Neoleukin Therapeutics Inc
NLTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.2M
Close$
$6.08
74.2% upside
Current Fair Value
74.2% upsideUndervalued by 74.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.20 Million |
|---|---|
| Enterprise Value | $-95,940,315.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.1 |
| Outstanding Shares | 22,552,032 |
Return
| Return on Equity | -51.17% |
|---|---|
| Return on Assets | -45.47% |
| Return on Invested Capital | -54.45% |
Valuation & Multiples
| P/E Ratio | -4.42 |
|---|---|
| PEG | -7.8 |
| Price to Sales | - |
| Price to Book Ratio | 0.39 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.79 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data